Laropharm S.R.L.
Laropharm S.R.L., a prominent player in the pharmaceutical industry, is headquartered in Romania (RO) and operates extensively across Eastern Europe. Founded in 1998, the company has established itself as a leader in the development and distribution of high-quality pharmaceutical products, particularly in the fields of oncology, cardiology, and neurology. With a commitment to innovation, Laropharm S.R.L. offers a diverse portfolio of prescription medications and over-the-counter solutions that stand out for their efficacy and safety. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, Laropharm S.R.L. continues to contribute to the advancement of healthcare, making a meaningful impact on patients' lives across the region.
DitchCarbon Score
How does Laropharm S.R.L.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laropharm S.R.L.'s score of 28 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laropharm S.R.L.'s reported carbon emissions
In 2023, Laropharm S.R.L. reported total carbon emissions of approximately 13,275,740 kg CO2e. This figure includes 9,493,390 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 5,370,100 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. Comparatively, in 2022, the company recorded total emissions of about 9,937,240 kg CO2e, with Scope 1 emissions at 9,937,240 kg CO2e and Scope 2 emissions at 5,259,210 kg CO2e. This indicates a significant increase in emissions from 2022 to 2023. In 2019, Laropharm's total emissions were approximately 14,524,910 kg CO2e, with Scope 1 emissions at 10,920,800 kg CO2e and Scope 2 emissions at 4,996,690 kg CO2e. Despite these figures, there are currently no disclosed reduction targets or climate pledges from Laropharm S.R.L. This absence of specific commitments highlights a potential area for improvement in their climate strategy. The company has not reported on Scope 3 emissions, which include all other indirect emissions not covered in Scope 2. Overall, while Laropharm S.R.L. has made strides in emissions reporting, the lack of reduction initiatives or targets suggests a need for enhanced climate action and commitment to sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 10,920,800 | 0,000,000 | 0,000,000 |
| Scope 2 | 4,996,690 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Laropharm S.R.L. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
